Sarasin & Partners LLP Grows Holdings in Intuitive Surgical, Inc. $ISRG

Sarasin & Partners LLP lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 128.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 244,426 shares of the medical equipment provider’s stock after purchasing an additional 137,302 shares during the period. Intuitive Surgical comprises about 1.1% of Sarasin & Partners LLP’s portfolio, making the stock its 28th largest holding. Sarasin & Partners LLP owned 0.07% of Intuitive Surgical worth $97,203,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Evanson Financial LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $218,000. 180 Wealth Advisors LLC lifted its position in shares of Intuitive Surgical by 21.1% during the 2nd quarter. 180 Wealth Advisors LLC now owns 5,434 shares of the medical equipment provider’s stock valued at $2,161,000 after buying an additional 946 shares in the last quarter. JGP Wealth Management LLC grew its stake in Intuitive Surgical by 9.5% in the 2nd quarter. JGP Wealth Management LLC now owns 2,323 shares of the medical equipment provider’s stock valued at $924,000 after acquiring an additional 202 shares during the period. Willner & Heller LLC grew its stake in Intuitive Surgical by 3.7% in the 2nd quarter. Willner & Heller LLC now owns 3,510 shares of the medical equipment provider’s stock valued at $1,396,000 after acquiring an additional 125 shares during the period. Finally, Central Pacific Bank Trust Division increased its holdings in Intuitive Surgical by 0.8% in the 2nd quarter. Central Pacific Bank Trust Division now owns 5,028 shares of the medical equipment provider’s stock worth $2,000,000 after acquiring an additional 38 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $373.71 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The stock’s fifty day moving average is $393.78 and its two-hundred day moving average is $446.25. The firm has a market capitalization of $132.02 billion, a P/E ratio of 42.81, a PEG ratio of 2.71 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.81 earnings per share. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. BMO Capital Markets restated an “outperform” rating on shares of Intuitive Surgical in a research report on Monday, July 20th. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Tuesday, May 19th. BTIG Research cut their target price on shares of Intuitive Surgical from $512.00 to $469.00 and set a “buy” rating for the company in a research note on Friday, July 17th. Leerink Partners reduced their price target on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a research report on Friday, July 17th. Finally, UBS Group started coverage on shares of Intuitive Surgical in a research report on Tuesday, July 28th. They set a “neutral” rating and a $500.00 price target for the company. Twenty investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $509.02.

Insider Activity

In other news, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares in the company, valued at $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction that occurred on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the sale, the executive vice president directly owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This represents a 6.54% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 6,634 shares of company stock valued at $2,796,795. 0.60% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.